IL18 and inflammatory bowel disease: Results indicated that IL-18 plays a role in IBD risk due to changes in gene expression within monocytes (PPAabc = 88.12%) and neutrophils (PPAabc = 96.57%), but not T cells (PPAabc = 1.59%) (Fig. 3A).